2021 Finalists

Congratulations to the finalists who have been recognized by their peers for the inspiring work they do each day – all collectively working to make a difference for those living with and affected by cancer.

C2 Catalyst for Care Award

Finalists for this award bring high-quality cancer care to underserved populations. Consequently, their work drives change at the community-, neighborhood- or hospital-level that results in better cancer care for more people.

Unite for HER

Unite for HER

Represented by
Susan Weldon
CEO & Founder

Andie McConnell, MA

Andie McConnell, MA

Executive Director & Co-Founder,
Fairy Godmother Project

Pancreatic Cancer Action Network - Patient Services

Pancreatic Cancer Action Network - Patient Services

Represented by
Julie Fleshman, JD, MBA
President & CEO
with Case Managers Alejandra Villa and Sean Gonzales


C2 Catalyst for Change Award

Finalists for this award significantly improve the cancer care experience for patients and their loved ones. As a result, the work of these finalists makes a patient’s experience as easy as possible during an extraordinarily difficult time.

Tomma Hargraves

Tomma Hargraves

Lung Cancer Advocate & Volunteer,
Lung Cancer Initiative of North Carolina

Stacie Lindsey

Stacie Lindsey

CEO & Founder,
Cholangiocarcinoma Foundation

Stephenie K. Kennedy-Rea, EdD, MA

Stephenie K. Kennedy-Rea, EdD, MA

Associate Director for Cancer Prevention and Control,
WVU Cancer Institute


C2 Catalyst for Equity Award

Finalists for this award have worked to overcome longstanding racial and ethnic disparities in cancer care, ensuring that all patients have equitable access to quality care.

Equal Hope

Equal Hope

Represented by
Anne Marie Murphy, PhD
Executive Director

Carmen Ortiz, PhD

Carmen Ortiz, PhD

Executive Director,
Circulo de Vida

Beulah Brent

Beulah Brent

CEO,
Sisters Working It Out


C2 Catalyst for Precision Medicine Award

Finalists for this award significantly advance precision medicine in oncology to bring new, more personalized tests or treatments to patients. As such, these finalists enhance the ability to provide the right treatment for the right patient at the right time.

Colin Pritchard, MD, PhD

Colin Pritchard, MD, PhD

Director of Clinical Diagnostics,
Brotman Baty Institute for Precision Medicine of UW

Jonathan Simons, MD

Jonathan Simons, MD

Board Member,
Prostate Cancer Foundation

Alana Welm, PhD

Alana Welm, PhD

Professor & Senior Director of Basic Science, Huntsman Cancer Institute